m.restrepo
TL2 Moderator · Cork
Contributes reviews on supplier material. Based in Cork.
Joined 26 September 2025 · last posted 2d
67 posts, newest first. Showing up to 150.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #98 · Practice › Dosing & titration · 26 Jul 2026 · 18 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #18 · Compounds › Tirzepatide · 25 Jul 2026 · 2 likes Coming back to post #16, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Common supplements people ask about, assessed one at a time Replied, post #57 · Practice › Interactions · 17 Jul 2026 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Blinding yourself: practical methods and their limits Replied, post #41 · Research Methods › N-of-1 designs · 9 Jul 2026 · 4 likes Picking up post #38: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
What I would want from a home test that does not exist yet Replied, post #32 · Analytics › Home & field testing · 9 Jul 2026 · 18 likes Worth separating two things that post #28 runs together. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #33 · Evidence › Journal club · 7 Jul 2026 · 22 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Tracking a shortage from primary sources rather than rumour Replied, post #87 · Access › Shortages · 6 Jul 2026 · 27 likes Coming back to post #85, because the follow-up matters more than the original answer. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
-
[2026 update] Second opinions: how to seek one without burning the first Replied, post #2 · marked as the solution · Clinical › Prescriber conversations · 3 Jul 2026 · 14 likes Coming back to the opening post, because the follow-up matters more than the original answer. Discussing side effects: be specific. "Nausea" is less useful than "I have…
-
Prescription requirements and telehealth models — a second dataset Replied, post #70 · Sourcing › Regulatory · 18 Jun 2026 · 11 likes On post #66 — agreed on the reasoning, with one qualification. Off-label use and medical practice: clinicians can prescribe approved medications off-label under some…
-
Pooling trials with different estimands Replied, post #8 · Evidence › Meta-analyses · 5 Jun 2026 · 7 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Second pass at: When your prescriber and the evidence disagree Replied, post #29 · Clinical › Prescriber conversations · 31 May 2026 · 3 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Follow-up: Sleep quality changes during weight loss Replied, post #16 · Wellbeing › Sleep · 5 May 2026 · 15 likes post #15 is right about the mechanism and I think understates the practical bit. Gastrointestinal effects overnight: nausea or reflux or constipation at night can…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #115 · Pharmacology › Pharmacokinetics · 22 Apr 2026 · 17 likes Picking up post #112: that is the part I would want checked first. Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #40 · Devices › Syringes & needles · 18 Apr 2026 · 7 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #78 · Clinical › Special populations · 19 Mar 2026 · 2 likes This follows post #75 rather than contradicting it. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the…
-
A site rotation scheme that is easy enough to actually follow Replied, post #21 · Practice › Administration · 16 Mar 2026 · 2 likes post #20 answers the question as asked. The question underneath it is different. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue…
-
MHRA statements, read directly Replied, post #83 · Regional › UK & Ireland · 6 Feb 2026 · 0 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #32 · Pharmacology › Pharmacokinetics · 3 Feb 2026 · 16 likes post #31 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Reading an interaction checker output critically Replied, post #102 · Practice › Interactions · 26 Jan 2026 · 29 likes This follows post #99 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #8 · Clinical › Special populations · 20 Jan 2026 · 12 likes Picking up post #5: that is the part I would want checked first. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #61 · Clinical › Special populations · 27 Dec 2025 · 2 likes Coming back to post #59, because the follow-up matters more than the original answer. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 26 Dec 2025 · 0 likes On post #20 — agreed on the reasoning, with one qualification. The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #48 · Compounds › Semaglutide · 25 Dec 2025 · 10 likes Picking up post #45: that is the part I would want checked first. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #7 · Analytics › COA interpretation · 23 Dec 2025 · 0 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #11 · Access › International · 13 Dec 2025 · 14 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Tracking a preprint to publication: a worked example Replied, post #45 · Evidence › Preprints · 4 Dec 2025 · 6 likes Coming back to post #43, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #27 · Pharmacology › Pharmacokinetics · 27 Nov 2025 · 30 likes On post #23 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #12 · Safety › Contraindications · 26 Nov 2025 · 15 likes Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the…
-
Lurking for two months before posting: was that the right call? Replied, post #49 · Start Here › Welcome · 19 Nov 2025 · 0 likes This follows post #46 rather than contradicting it. Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer…
-
Pen dose counters: what a click does and does not guarantee Replied, post #29 · Devices › Pens & autoinjectors · 14 Nov 2025 · 0 likes post #28 answers the question as asked. The question underneath it is different. Reusability: some pens are single-use (throw away after one injection). Others can be…
-
What a purity-only report leaves out Replied, post #56 · Sourcing › Independent verification · 22 Oct 2025 · 0 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #14 · Analytics › Impurities & related substances · 18 Oct 2025 · 21 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Thyroid function tests during substantial weight change Replied, post #93 · Clinical › Bloodwork · 12 Oct 2025 · 0 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #61 · Practice › Reconstitution · 28 Sep 2025 · 29 likes Worth separating two things that post #57 runs together. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and…
-
Reporting a disappointing outcome, and why it belongs here Replied, post #30 · Outcomes › Progress reports · 27 Sep 2025 · 19 likes post #29 answers the question as asked. The question underneath it is different. Seasonal patterns: some people report weight loss is slower in winter than summer. Body…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #23 · Analytics › Method validation · 26 Sep 2025 · 0 likes Coming back to post #21, because the follow-up matters more than the original answer. Forced degradation studies: deliberately stress the material with acid, base,…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #68 · Analytics › HPLC & UHPLC · 13 Sep 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #72 · Evidence › Journal club · 3 Sep 2025 · 0 likes post #71 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
What I would record differently if I started again — the long version Replied, post #6 · Outcomes › Progress reports · 4 Aug 2025 · 14 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
A ten-fold dose error caught before injection Replied, post #75 · Devices › Syringes & needles · 2 Aug 2025 · 13 likes post #74 answers the question as asked. The question underneath it is different. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G)…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 22 Jul 2025 · 21 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Revisiting: Filing a first vendor report: a worked example Replied, post #2 · Sourcing › Vendor reports · 7 Jul 2025 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #3 · Analytics › HPLC & UHPLC · 6 Jul 2025 · 0 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #75 · Access › Insurance & coverage · 12 Jun 2025 · 31 likes On post #71 — agreed on the reasoning, with one qualification. Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #46 · Nutrition & Training › Protein & intake · 9 Jun 2025 · 3 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #22 · Evidence › Journal club · 1 Jun 2025 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #7 · Analytics › Method validation · 21 May 2025 · 31 likes I read post #5 twice before replying, because I had assumed the opposite. Robustness: the method gives consistent results when minor parameters vary. Tested by…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #143 · Sourcing › Regulatory · 3 May 2025 · 0 likes I read post #141 twice before replying, because I had assumed the opposite. Regulatory positions change: a compound's status today might differ from its status a year…
-
Fibre intake when total intake falls, and the constipation link Replied, post #54 · Nutrition & Training › Protein & intake · 15 Apr 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #49 · Practice › Reconstitution · 13 Apr 2025 · 0 likes post #48 answers the question as asked. The question underneath it is different. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
-
Follow-up: What other technical communities get right that we do not Replied, post #65 · Lounge › Off topic · 12 Apr 2025 · 11 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #23 · Sourcing › Vendor reports · 15 Mar 2025 · 27 likes Worth separating two things that post #19 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #66 · Compounds › Semaglutide · 16 Feb 2025 · 6 likes Worth separating two things that post #62 runs together. The mass figure differs between sources because of how the different entities report it. The monoisotopic mass…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #30 · Evidence › Journal club · 31 Jan 2025 · 4 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #71 · Evidence › Journal club · 25 Dec 2024 · 17 likes This follows post #68 rather than contradicting it. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #98 · Compounds › Tirzepatide · 20 Dec 2024 · 9 likes Coming back to post #96, because the follow-up matters more than the original answer. Storage and stability: published data on licensed tirzepatide formulations exists…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #6 · Compounds › Semaglutide · 18 Dec 2024 · 27 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
A promotion I argued against, and why I lost Replied, post #14 · Documentation › Doc review · 26 Nov 2024 · 3 likes post #13 is right about the mechanism and I think understates the practical bit. Interdependencies: if updating one page requires updating related pages, posting that…
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #22 · Nutrition & Training › Resistance training · 14 Nov 2024 · 30 likes Cardio and resistance: the interaction between energy-intense cardiovascular training and resistance training is real. Moderate cardio is fine; excessive endurance…
-
Time to steady state after a dose increase Replied, post #58 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 0 likes This follows post #55 rather than contradicting it. Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but…
-
When a red flag was a misunderstanding, and the retraction Replied, post #34 · Sourcing › Red flags · 14 Oct 2024 · 12 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
Blind submission and why it changes minds Replied, post #66 · Sourcing › Independent verification · 20 Sep 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Progressive overload when the scale is falling — one year on Replied, post #7 · Nutrition & Training › Resistance training · 26 Aug 2024 · 1 like Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…
-
Chronic kidney disease and the FLOW result Replied, post #10 · Clinical › Comorbidities · 12 Aug 2024 · 1 like Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Circumference measurements as a poor man's composition estimate Replied, post #36 · Outcomes › Body composition · 2 Aug 2024 · 6 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Pancreatitis history and the risk calculus — a second dataset Replied, post #3 · Safety › Contraindications · 26 Jul 2024 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Disordered eating history: appetite suppression can trigger relapse in people with…
-
How to ask for a dose change without antagonising anyone Replied, post #5 · Clinical › Prescriber conversations · 13 Jul 2024 · 6 likes Coming back to post #3, because the follow-up matters more than the original answer. Discussing off-label dosing: if you want to dose differently than the label…